Page results
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
This page provides information about the thermoregulatory sweat test (TST).
-
Patient information leaflet for Functional Electrical Stimulation (FES) Clinic
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
HTD Outpatients offers a wide range of clinics for Chagas disease, Infectious diseases, Leishmaniasis, Leprosy , Malaria , Microbiology, Neglected tropical diseases, Parasitology
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
Information about energy conservation for UCLH patients with mitochondrial disease.
-
Paediatric Audio-vestibular Medicine provides investigation, diagnosis and management of the medical aspect of disorders of hearing, balance and tinnitus in children. The service consists of a multi-professional team and is located at The Royal National ENT & Eastman Dental Hospitals, 47-49 Huntley Street London WC1E 6DG.
-
The fertility laboratory provides three main services. Semen analysis to test fertility, storage of semen samples and processing of semen samples for IUI treatments.
-
Paediatric audiology is based at the Royal National ENT & Eastman Dental Hospital. The service provides Audiological assessments for children ranging from new-borns to 18 year olds.
File results
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0578 - Spinal Muscular Atrophy (SMA) patients